SKYE
COM:SKYEBIOSCIENCE
Skye Bioscience
- Stock
Last Close
5.39
13/11 21:00
Market Cap
163.52M
Beta: -
Volume Today
115.71K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 6.51K - | 6.51K 0% | |||||||||
average payables | 3.12K - | 205.82K 6,505.42% | 267.43K 29.93% | 200.00K 25.21% | 187.79K 6.11% | 58.26K 68.98% | 77.70K 33.38% | 260.59K 235.37% | 640.69K 145.86% | 1.35M 110.31% | |
average receivables | 18.64K - | 12.67K 32.04% | |||||||||
book value per share | -0.02 - | -0.04 87.98% | 0.03 163.10% | -0.08 375.39% | -0.03 62.56% | -0.13 348.02% | 0.00 103.16% | 0.00 51.82% | 0.01 638.25% | -0.01 137.56% | |
capex per share | -0.01 - | -0.00 64.24% | -0.00 94.82% | -0.00 401.42% | -0.00 20.04% | -0.00 94.86% | -0.00 - | -0.00 613.23% | -0.00 77.39% | ||
capex to depreciation | -4.52 - | -12.19 169.87% | -0.20 98.37% | -0.75 274.27% | -2.44 228.03% | -2.84 16.16% | -3.86 - | -2.66 31.07% | -0.24 90.83% | ||
capex to operating cash flow | 3.39 - | 0.01 99.61% | 0.00 95.99% | 0.00 488.53% | 0.01 90.45% | 0.00 81.34% | 0.00 - | 0.01 1,075.12% | 0.00 84.31% | ||
capex to revenue | -0.14 - | ||||||||||
cash per share | 0.01 - | 0.02 199.94% | 0.19 844.02% | 0.00 98.20% | 0.01 172.29% | 0.02 64.22% | 0.01 11.49% | 0.01 20.96% | 0.02 106.44% | 0.00 89.86% | |
days of inventory on hand | 36.18 - | ||||||||||
days payables outstanding | 5.98 - | ||||||||||
days sales outstanding | 27.21 - | ||||||||||
debt to assets | 0.32 - | 0.42 - | 0.70 64.89% | 0.19 72.12% | 0.56 189.20% | 0.22 61.34% | 0.21 2.41% | ||||
debt to equity | -0.26 - | -0.29 - | -0.09 70.23% | 0.71 907.59% | 3.32 370.46% | 0.36 89.04% | -0.64 275.88% | ||||
dividend yield | |||||||||||
earnings yield | -0.00 - | -0.00 2,112.15% | -0.00 1,091.11% | -0.00 36.03% | -0.00 31.34% | -0.00 45.71% | 0.00 115.05% | -0.00 1,292.12% | -0.00 43.29% | -0.01 437.31% | |
enterprise value | 19.42B - | 19.94B 2.65% | 2.96B 85.15% | 1.43B 51.69% | 1.06B 25.87% | 12.11B 1,042.48% | 4.41B 63.61% | 2.31B 47.68% | 5.28B 128.87% | 2.25B 57.39% | |
enterprise value over ebitda | -161.33K - | -7.30K 95.47% | -618.32 91.54% | -246.70 60.10% | -282.90 14.67% | -2.51K 786.98% | -663.56 73.56% | -366.86 44.71% | -675.47 84.12% | -186.02 72.46% | |
ev to operating cash flow | -1.34M - | -11.36K 99.15% | -794.26 93.01% | -402.61 49.31% | -321.51 20.14% | -3.07K 855.65% | -731.37 76.20% | -380.98 47.91% | -815.30 114.00% | -176.52 78.35% | |
ev to sales | 57.14K - | ||||||||||
free cash flow per share | -0.01 - | -0.17 2,010.78% | -0.22 27.43% | -0.19 14.58% | -0.12 36.79% | -0.03 72.60% | -0.04 36.89% | -0.03 41.10% | -0.02 38.53% | -0.02 42.44% | |
free cash flow yield | -0.00 - | -0.00 2,623.58% | -0.00 1,310.86% | -0.00 97.99% | -0.00 25.58% | -0.00 89.59% | -0.00 319.52% | -0.00 92.18% | -0.00 52.71% | -0.01 357.22% | |
graham net net | -0.01 - | -0.06 329.74% | 0.01 118.51% | -0.09 943.57% | -0.04 56.42% | -0.13 228.83% | 0.00 102.18% | 0.00 61.83% | 0.01 1,040.19% | -0.02 259.51% | |
graham number | 0.09 - | 0.51 467.70% | 0.42 17.61% | 0.54 27.13% | 0.27 50.25% | 0.68 153.01% | 0.03 96.06% | 0.04 32.67% | 0.08 133.29% | 0.07 20.71% | |
income quality | 0.12 - | 0.64 433.24% | 0.77 19.96% | 1.12 45.18% | 1.07 4.66% | 0.21 80.73% | -5.73 2,889.77% | 0.92 116.10% | 0.76 17.67% | 0.65 13.90% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -55.98 - | -8.27 - | 3.45 141.80% | -5.79K 167,584.38% | -49.52 99.14% | -6.71 86.44% | -8.90 32.60% | -10.22 14.85% | -27.53 169.25% | ||
interest debt per share | 0.01 - | 0.03 - | -0.07 321.48% | 0.01 112.36% | 0.01 42.28% | 0.01 15.34% | 0.01 6.10% | 0.01 25.24% | 0.00 34.62% | ||
inventory turnover | 10.09 - | ||||||||||
invested capital | -0.26 - | -0.29 - | -0.09 70.23% | 0.71 907.59% | 3.32 370.46% | 0.36 89.04% | -0.64 275.88% | ||||
market cap | 19.43B - | 19.94B 2.65% | 2.96B 85.13% | 1.43B 51.74% | 1.06B 25.87% | 12.12B 1,042.50% | 4.41B 63.60% | 2.31B 47.68% | 5.29B 129.07% | 2.25B 57.45% | |
net current asset value | -76.02K - | -493.50K 549.17% | 413.73K 183.84% | -1.49M 461.29% | -801.49K 46.38% | -15.57M 1,842.11% | 546.08K 103.51% | 443.44K 18.79% | 5.62M 1,167.61% | -3.18M 156.49% | |
net debt to ebitda | 0.04 - | 0.08 84.82% | 0.67 785.64% | 0.01 98.34% | 0.01 40.45% | 0.10 1,431.92% | 0.22 112.94% | 0.15 28.84% | 0.88 466.92% | -0.06 106.44% | |
net income per share | -0.02 - | -0.27 1,614.41% | -0.29 7.58% | -0.17 41.31% | -0.11 33.89% | -0.16 42.88% | 0.01 104.91% | -0.03 465.34% | -0.02 26.28% | -0.04 67.39% | |
operating cash flow per share | -0.00 - | -0.17 9,041.94% | -0.22 29.05% | -0.19 14.80% | -0.12 36.97% | -0.03 72.46% | -0.04 37.04% | -0.03 41.17% | -0.02 39.31% | -0.02 44.12% | |
payables turnover | 61.00 - | ||||||||||
receivables turnover | 13.42 - | ||||||||||
research and ddevelopement to revenue | |||||||||||
return on tangible assets | -0.83 - | -7.85 849.77% | -1.38 82.43% | -9.83 612.79% | -5.55 43.50% | -9.81 76.61% | 0.53 105.37% | -2.46 566.16% | -0.86 64.78% | -2.14 147.27% | |
revenue per share | 0.04 - | ||||||||||
roe | 0.66 - | 6.03 812.01% | -10.28 270.50% | 2.19 121.31% | 3.87 76.56% | 1.23 68.11% | 1.92 55.60% | -14.55 858.34% | -1.45 90.01% | 6.48 545.65% | |
roic | 0.08 - | 6.03 7,833.96% | -9.17 252.10% | 3.08 133.62% | 6.83 121.65% | 0.33 95.16% | -7.08 2,243.07% | -3.23 54.42% | -0.96 70.21% | 18.28 2,000.18% | |
sales general and administrative to revenue | 0.35 - | ||||||||||
shareholders equity per share | -0.02 - | -0.04 87.98% | 0.03 163.10% | -0.08 375.39% | -0.03 62.56% | -0.13 348.02% | 0.00 103.16% | 0.00 51.82% | 0.01 638.25% | -0.01 137.56% | |
stock based compensation to revenue | |||||||||||
tangible asset value | -36.46K - | -453.55K 1,143.99% | 471.00K 203.85% | -1.45M 408.05% | -800.08K 44.86% | -15.56M 1,845.09% | 548.06K 103.52% | 450.79K 17.75% | 5.86M 1,200.88% | -3.01M 151.30% | |
tangible book value per share | -0.00 - | -0.04 839.18% | 0.03 163.10% | -0.08 375.39% | -0.03 62.56% | -0.13 348.02% | 0.00 103.16% | 0.00 51.82% | 0.01 638.25% | -0.01 137.56% | |
working capital | -76.02K - | -492.69K 548.12% | 2.87M 682.91% | -382.47K 113.32% | -250.16K 34.59% | -13.99M 5,490.47% | 1.02M 107.32% | 1.88M 83.33% | 5.70M 203.64% | -3.18M 155.71% |
All numbers in (except ratios and percentages)